Jill Wilson

Jill Wilson has had a long and varied career in the medical and pharmaceutical industries. Jill began in 1997 as an Office Coordinator at Tyco/Mallinckrodt and then moved on to Eastern Isotopes, Inc. in 2001 as an Office Manager. In 2002, they were promoted to General Manager at Eastern Isotopes' Little Ferry and Somerset facilities. In 2006, they moved to IBA Molecular North America, Inc. as Director of Staff Development and Regional Operations for the Northeast and Florida. In 2009, they were promoted to Director of Quality Management System (QMS) at IBA Molecular North America, Inc. (fka Eastern Isotopes, Inc.). In 2016, they became Interim Head of QA/RA/EH&S at Zevacor Pharma, Inc. (nka SOFIE Co.). In 2017, they founded Meistrich-Wilson Consulting LLC as President and in 2018, they were promoted to Senior Director of Regulatory Affairs & Quality Assurance at Ionetix Corporation.

Jill Wilson attended RAPS University from 2015 to 2016 and obtained a Regulatory Affairs Certificate in Medical Devices. Jill also attended Regulatory Affairs Professional Society (RAPS) from 2011 to 2012 and obtained a Regulatory Affairs Certificate in Pharmaceuticals. Jill Wilson obtained their BA from Montclair State University in Consumer Affairs. Jill graduated from Ocean Township High School. Additionally, they have obtained a Regulatory Affairs Certification.